Corporadelic

Article

DARE to Resist White Supremacy and The Police

American policing is a white supremacist institution that has repeatedly demonstrated the degree to which it values property over human life.

Article

MindMed’s CEO Jamon “JR” Rahn Wants Nothing To Do With Those Psychedelic Decrim People

“I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes.”

Article

Field Trip Announces “World’s First” Virtual Psychedelic Therapy, But Forgets To Mention They Aren’t the First and No Psychedelics Are Involved

Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.

Article

Bicycle Day 2020 Was Truly Historic, But Not for the Reasons You Think

Jamon A. Rahn, CEO of psychedelic pharmaceutical startup MindMed, offered a glimpse of the future of psychedelic science, including proprietary data and hints of an “LSD neutralizer.”

Article

Amidst Pandemic, Psychedelic Investor Christian Angermayer Can’t Imagine Life Beyond Capitalism

As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”

Article

“Flattening The Curve is Complete BS”: Pandemic Advice From Psychedelic Investor Christian Angermayer

In response to the coronavirus pandemic, Christian Angermayer—the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences—dismisses medical experts in his desperation to reboot the economy.

Article

Dear Psychedelic Researchers

The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.

Article

Calm Down. What’s the Worst Thing That the Wellness Industry Could Do to Psychedelics?

As technology and psychedelics turn to mental health, we’ll likely see a future where we are treated based on our digital biomarkers, and sold mental health services based on the personal data we surrender.

Article

Talking Psychedelic Capitalism in a WeWork Ballroom

Psychedelic capitalists justify their decision to go for-profit in the ballroom of America’s most recent for-profit flop.

Article

Christian Angermayer’s ATAI Life Sciences is positioned to take the psychedelic throne from MAPS

After decades of psychedelic nonprofits paving regulatory pathways and priming wealthy investors, for-profits are moving in to reap the rewards.

Article

“Making psychedelics boring again”— Unless you’re a privileged psychedelic executive, of course

The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.

Article

Psychedelic Trade Secrets and Get-Rich-Quick Schemes —a Benefit to Investors, a Harm to Progress

“Play the field right and there’s money to be made even off some of the shit companies purely based on the wave.”